The Association Between Disease Duration and Both Endoscopic and Histological Findings in Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) is a long-term illness that causes inflammation (swelling and damage) in the digestive system. The two main types of IBD are Crohn’s disease (CD) and ulcerative colitis (UC). CD most commonly affects the end of the small intestine and the beginning of the large intestine. UC causes inflammation and sores, called ulcers, in part of the digestive tract and affects the innermost lining of the large intestine, called the colon, and rectum. Symptoms usually develop over time, rather than coming on suddenly. People with IBD often experience ongoing symptoms such as stomach pain, diarrhea, and fatigue, with periods of flare-ups and relief. The number of people living with IBD is increasing, especially in North America, Europe, and many developing countries. As more people are diagnosed, it becomes important to understand how the disease changes over time and how best to treat it.

Our research will explore whether having IBD for a longer time makes it harder for the gut to fully heal. Healing will be assessed using two tools: endoscopy (a camera used to view the inside of the gut) and histology (examining tissue samples under a microscope). These methods can detect signs of inflammation that may not be obvious through symptoms alone. In fact, current thinking suggests that healing seen on endoscopy or histology is more useful for predicting long-term health than symptoms alone.

Past research has shown that a longer disease duration may lead to worse outcomes in Crohn’s disease, but we still do not know if this also affects healing seen on endoscopy or histology in either CD or UC. Our study will help answer this question.

To do this, we will combine data from 18 previous clinical trials to create a large dataset with thousands of patients. This type of analysis, called a pooled analysis, allows us to look for patterns that smaller studies might miss. We will also take into account other important factors such as the patient’s age, type of treatment, and how severe their disease was when they started the study. This will help us better understand the true relationship between how long someone has had IBD and their chances of gut healing.

By doing this research, we aim to better understand how time with the disease affects the healing process. Our findings may help doctors make more informed treatment decisions and encourage earlier and more effective control of inflammation. Ultimately, this could lead to better long-term health and quality of life for people living with IBD.